Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Health Economic Publication Digest: Addressing the need for economic modelling when designing and reporting a diagnostic testing accuracy study

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest.  

In a recent publication, Xie et al. examined how diagnostic test accuracy (DTA) studies can better support economic modelling of new diagnostic tests. Based on a rapid review of economic evaluations published between 2012 and 2025, the authors proposed eight additional reporting elements to complement the STARD 2015 guideline (Standards for Reporting of Diagnostic Accuracy Studies). These include clearer reporting of diagnostic pathways, consequences of false results, disease prevalence, HRQoL, resource use, and considerations for AI-enabled tests. The proposed additions aim to improve the usability of DTA evidence in model-based economic evaluations and HTA decision-making. 

Access the full-text article here.